Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of A Low-Carbohydrate, High-Fat, Ketogenic Diet on Obesity, Metabolic Abnormalities and Psychiatric Symptoms in Patients With Bipolar or Schizophrenia Illness: A Pilot Trial

NCT03935854 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT03935854
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03935854 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of A Low-Carbohydrate, High-Fat, Ketogenic Diet on Obesity, Metabolic Abnormalities and Psychiatric Symptoms in Patients With Bipolar or Schizophrenia Illness: A Pilot Trial
Lead sponsor
Stanford University
Phase
Not applicable
Overall status
Completed
Start date
February 13, 2019
Completion date
August 11, 2022
Enrollment
23 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar disorder, brain metabolic disorder, ketogenic dieting, metabolic syndrome, obesity, psychotropic agents causing adverse effects in therapeutic use, schizophrenia, weight gain